Healthcare spending by government and private organizations has been increasing over the years. These high spending across the region is not only enhancing the healthcare infrastructure but also influencing the adoption of various technologically advanced solutions for improving their treatment plans and diagnostic procedures. Along with the investment in overall healthcare infrastructure, the government bodies have been assigning funds for enhancing various diagnostics processes such as magnetic resonance imaging (MRI) and computed tomography (CT) scan. Thus, the above-mentioned initiatives to promote various diagnostics processes are fueling the growth of the multimodal image fusion software market over the years.
North American countries are known for the highest acceptance for technologies, which also boosts the pace of development of new technologies in these countries. Rapid technological developments can also be attributed to favorable government policies to boost innovation and reinforce infrastructure capabilities. Thus, any impact on industries directly affects the region's economic development. The US is the world's worst-affected country by the COVID-19 outbreak, thus leading to the sudden stands still across all the industries present in the region. However, the healthcare sector in many of the North American countries has remained unaffected during the pandemic. In addition to the rising cases across countries such as the US, Canada, and Mexico, the high prevalence of diseases other than other COVID-19 has stimulated the demand for all healthcare equipment and solutions. As of 2020, there are ~5.8 million Americans living with Alzheimer’s disease.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the multimodal image fusion software market. The North America multimodal image fusion software market is expected to grow at a good CAGR during the forecast period.